Latest Articles

Publication Date
All News Scientific
Medicine, Schillaci: “Investing in women’s health means investing in a better society” - Ruetir

Medicine, Schillaci: “Investing in women’s health means investing in a better society” Ruetir

Published: Nov. 4, 2024, 6:05 p.m.
Read Full Article
Dr. Barbara McGuirk & Tara Hilton Team Up For Suicide Awareness In The Endo Community [63a0da] - University of Missouri School of Medicine

Dr. Barbara McGuirk & Tara Hilton Team Up For Suicide Awareness In The Endo Community [63a0da] University of Missouri School of Medicine

Published: Nov. 4, 2024, 11:33 a.m.
Read Full Article
Medicine, Sigo: "Gynecologists at a conference for 'women at the center of a new renaissance' - Ruetir

Medicine, Sigo: "Gynecologists at a conference for 'women at the center of a new renaissance' Ruetir

Published: Oct. 31, 2024, 6:55 p.m.
Read Full Article
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - The Week

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation The Week

Published: Oct. 25, 2024, 5:28 a.m.
Read Full Article
Five Things You Need To Know About Endometriosis - Yale School of Medicine

Five Things You Need To Know About Endometriosis Yale School of Medicine

Published: Oct. 24, 2024, 10:23 p.m.
Read Full Article
Women’s Health Research at Yale Initiates New Pilot Projects - Yale School of Medicine

Women’s Health Research at Yale Initiates New Pilot Projects Yale School of Medicine

Published: Oct. 24, 2024, 10:11 p.m.
Read Full Article
Hope Medicine touts favourable mid-stage data for endometriosis therapy - FirstWord Pharma

Hope Medicine touts favourable mid-stage data for endometriosis therapy FirstWord Pharma

Published: Oct. 24, 2024, 9:31 p.m.
Read Full Article
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - BioSpace

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation BioSpace

Published: Oct. 24, 2024, 5:36 a.m.
Read Full Article
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - PR Newswire

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation PR Newswire

Published: Oct. 24, 2024, 12:08 a.m.
Read Full Article
New Stroke Guidelines Include Sex-Specific Risks - Inside Precision Medicine

New Stroke Guidelines Include Sex-Specific Risks Inside Precision Medicine

Published: Oct. 23, 2024, 2:27 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!